$ARNA News S&P 500 back for another crack at major

New Post Public Reply Private Reply Replies (0) Message Board

Jan 13, 2015 at 12:20 PM

$ARNA News

S&P 500 back for another crack at major support 11:21 a.m. Jan. 31, 2014 - Michael Ashbaugh
Arena shares surge as marketer doubles sales force for diet drug 11:41 a.m. Oct. 15, 2013 - Russ Britt
Obesity drug makers jockey for position as analysts praise Vivus 12:06 p.m. Oct. 3, 2013 - Russ Britt
Hedge funds are buying these stocks right now 1:46 p.m. July 23, 2013 - Insider Monkey
5 stocks insiders are buying 1:52 p.m. June 7, 2013 - Insider Monkey
6 gut checks before the stock market's opening bell 6:47 a.m. March 7, 2013 - Shawn Langlois
Stocks to watch Monday: Transocean, Stratasys 9:22 a.m. March 4, 2013 - Sue Chang
Arena Pharmaceuticals down 7.4% in premarket 9:11 a.m. Jan. 22, 2013 - Steve Gelsi
What 2012’s winners and losers say about 2013 6:00 a.m. Dec. 14, 2012 - Howard Gold
6 gut checks before the stock market's opening bell 6:50 a.m. Dec. 12, 2012 - Shawn Langlois
4 charts challenging resistance 7:06 a.m. Oct. 16, 2012 - The Trading Deck
Vivus sees EU regulators rejecting diet drug 12:16 p.m. Sept. 21, 2012 - MarketWatch.com
Vivus falls 11% on EU drug approval update 11:07 a.m. Sept. 21, 2012 - Val Brickates Kennedy
Arena rises as Vivus sees anti-obesity setback 7:49 a.m. Sept. 21, 2012 - Greg Morcroft
Vivus says Europe likely to reject obesity drug 7:33 a.m. Sept. 21, 2012 - MarketWatch.com
Orexigen soars 19% on analyst buy rating 12:46 p.m. Sept. 6, 2012 - Val Brickates Kennedy
Arena jumps 12% amid takeover speculation 1:55 p.m. Aug. 14, 2012 - Val Brickates Kennedy
Arena trips Nasdaq short-sale circuit breaker 3:01 p.m. Aug. 1, 2012 - Val Brickates Kennedy
Arena Pharma share drop trips short-sale limit 2:16 p.m. Aug. 1, 2012 - Laura Mandaro
Eisai gears up for launch of Arena's diet drug 9:32 a.m. July 30, 2012 - Val Brickates Kennedy

Arena starts PAH study ralinepag 4:40 p.m. Jan. 12, 2015 - Seeking Alpha
Arena starts ralinepag PAH study 4:40 p.m. Jan. 12, 2015 - Seeking Alpha
Expect Arena's Belviq To Increase U.S. Market Share During 2015 Weight Loss Season 3:04 p.m. Jan. 12, 2015 - Seeking Alpha
A Deeper Look At Arena's Belviq Pricing 3:02 p.m. Jan. 12, 2015 - Seeking Alpha
Arena Pharmaceuticals (ARNA) Is Today's Strong On High Volume Stock 10:02 a.m. Jan. 12, 2015 - TheStreet.com
Orexigen's Contrave May Have Pricing Competition 9:13 a.m. Jan. 12, 2015 - Seeking Alpha
Arena Pharmaceuticals (ARNA) in Focus: Stock Falls 5.7% - Tale of the Tape 8:38 a.m. Jan. 12, 2015 - Zacks.com
Seeking Alpha's Biotech Weekly: Gilead Rises With Phenex, Bass's Patent Attack, And More 4:00 p.m. Jan. 9, 2015 - Seeking Alpha
Sales Of Arena's Belviq Close Out 2014 - What Will 2015 Bring? 2:49 p.m. Jan. 9, 2015 - Seeking Alpha
Arena Investors Should Watch New Pricing Of Belviq Closely 12:20 p.m. Jan. 9, 2015 - Seeking Alpha
Arena's APD334 Has Real Blockbuster Potential 11:23 a.m. Jan. 9, 2015 - Seeking Alpha
Arena Pharmaceuticals Soars on Positive Study Results - Analyst Blog 5:20 p.m. Jan. 8, 2015 - Zacks.com
Today's Perilous Reversal Stock: Arena Pharmaceuticals (ARNA) 9:46 a.m. Jan. 8, 2015 - TheStreet.com
Mid-Day Market Update: J C Penney Jumps On Strong Holiday Sales; Micron Shares Decline 12:11 p.m. Jan. 7, 2015 - benzinga.com
Arena Spikes On Pipeline News 11:02 a.m. Jan. 7, 2015 - Seeking Alpha
Arena autoimmune disease candidate successful in Phase 1b 10:41 a.m. Jan. 7, 2015 - Seeking Alpha
Why JCPenney, Dick’s and Arena Pharmaceuticals Are 3 of Today’s Best Stocks 10:34 a.m. Jan. 7, 2015 - InvestorPlace.com
Mid-Morning Market Update: Markets Surge; Monsanto Profit Tops Estimates 9:59 a.m. Jan. 7, 2015 - benzinga.com
Arena Pharmaceuticals (ARNA) Showing Signs Of A Dead Cat Bounce Today 9:45 a.m. Jan. 7, 2015 - TheStreet.com
ARNA Stock Pops, And There’s Plenty More Where That Came From 9:11 a.m. Jan. 7, 2015 - InvestorPlace.com

Reveal Insider Trading for Yahoo, PulteGroup, Arena Pharmaceuticals, SolarCity, Alcoa, and Agenus 8:45 a.m. Today - PR Newswire - PRF
Arena Pharmaceuticals Initiates Phase 2 Clinical Trial Evaluating Ralinepag for Pulmonary Arterial Hypertension 8:00 a.m. Jan. 12, 2015 - PR Newswire - PRF
Reveal Earnings Forecast for Arena Pharmaceuticals, Petrobras, Alibaba, Apple, Gilead Sciences, and Applied Materials 8:45 a.m. Jan. 9, 2015 - PR Newswire - PRF
Arena Pharmaceuticals Reports on Eisai's New Marketing Initiatives for BELVIQ® (lorcaserin HCl) CIV 8:00 a.m. Jan. 9, 2015 - PR Newswire - PRF
Critical Alerts For JC Penney, Arena Pharmaceuticals, Dick's Sporting Goods, International Business Machines and Cisco Systems Released By InvestorsObserver 9:31 a.m. Jan. 8, 2015 - PR Newswire - PRF
Insider Trading Research for Apple, Twitter, Las Vegas Sands, Google, Arena Pharmaceuticals, and J C Penney 8:45 a.m. Jan. 8, 2015 - PR Newswire - PRF
Arena Pharmaceuticals Reports Positive Results from Phase 1b Clinical Trial Evaluating APD334 for the Treatment of Autoimmune Diseases 8:00 a.m. Jan. 7, 2015 - PR Newswire - PRF
Arena Pharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference 8:00 a.m. Jan. 6, 2015 - PR Newswire - PRF
Technical Coverage on Biotech Stocks - Arena Pharma, XOMA, Dyax, Mast Therapeutics, and Tekmira Pharma 8:50 a.m. Jan. 2, 2015 - PR Newswire - PRF
Arena Pharmaceuticals Issued Composition of Matter Patent by United States Patent and Trademark Office for Ralinepag and Related Compounds 8:00 a.m. Nov. 25, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 8:00 a.m. Nov. 24, 2014 - PR Newswire - PRF
Technical Updates on Biotech Stocks - ImmunoGen, Lexicon Pharma, ZIOPHARM Oncology, Arena Pharma, and Regulus Therapeutics 8:40 a.m. Nov. 19, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Present at Stifel 2014 Healthcare Conference 8:00 a.m. Nov. 13, 2014 - PR Newswire - PRF
Lorcaserin HCl Data to be Presented at the Annual Meeting of the American Association for the Study of Liver Diseases 8:00 a.m. Nov. 6, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Present at Credit Suisse 2014 Healthcare Conference 8:00 a.m. Nov. 5, 2014 - PR Newswire - PRF
Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2014 Financial Results 6:45 a.m. Nov. 3, 2014 - PR Newswire - PRF
Eisai and Arena Pharmaceuticals Report Results of an Investigational Phase 2 Trial of Lorcaserin HCl as an Aid for Smoking Cessation 6:30 a.m. Nov. 3, 2014 - PR Newswire - PRF
Lorcaserin Data to be Presented at The Obesity Society's Annual Scientific Meeting 8:37 a.m. Oct. 31, 2014 - PR Newswire - PRF
Lorcaserin Data to be Presented at The Obesity Society's Annual Scientific Meeting 8:00 a.m. Oct. 31, 2014 - PR Newswire - PRF
Eisai and Arena Pharmaceuticals Report Results of an Investigational Pilot Study of Coadministration of Lorcaserin HCl and Phentermine HCl 6:20 p.m. Oct. 28, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

SRG DocketWatch: Tracking FCC Docs in Real-Time

I'll admit it—sometimes the FCC moves like molasses uphill. But keeping track of what they're up to? That's where the real challenge lies. Summit Ridge Group has tossed a lifeline for anyone who's got skin in the game with their new service, SRG DocketWatch. Why SRG DocketWatch Hits the Mark If you're poking your head into more than a few of those 21,000 FCC...

XPENG Eyes South Korea Entry with Industry Veteran

A Veteran's Task in a New Territory Piling onto its international ambitions, XPENG has roped in Lee Man-sik, a seasoned auto industry professional, to break into South Korea. South Korea isn’t just another market—it’s one of the toughest stages for the automotive industry. The customers there are sharp, with a keen eye for tech and quality. So XPENG, trading under...

New Study Exposes Grim Reality for Moderate Aortic Stenosis

Uncovering the Stark Truth of Moderate Aortic Stenosis When you hear about heart issues, the last thing you want to think about is moderate anything. But this study out of San Diego sure throws a wrench in how we size up moderate aortic stenosis. Turns out these patients aren't just in a holding pattern—they're facing some serious storm clouds. High Stakes for...

PG&E, Edison Push Liability Cap Amid Firestorm

The Thanksgiving Playbook Nobody Wanted Sacramento's corridors are buzzing with electric tension. And why? It's not some trivial turkey drama but a simmering scandal over two utility giants trying to sneak a liability cap into law faster than you can ask for a second slice of pumpkin pie. PG&E and Edison have a little secret—a covert strategy to limit shareholder...

SecureSpace Expands into Dallas-Fort Worth Market

A New Player in Dallas-Fort Worth SecureSpace Self Storage has stormed into the Dallas-Fort Worth area, ushering in a sizeable expansion with four brand-new locations. This move is big news for the self-storage operator, marking its very first foray into the Texan market and boosting its nationwide presence past that century mark – 101 stores and counting. Call it a...

Vanity Fair Lingerie Reveals New Smoothing Bra

A Bra Revolution or Just Another Launch? I'll admit it, lingerie isn't the usual breakfast discussion for me, but Vanity Fair Lingerie's move with their new Flawlessly Smooth™ Bra piqued my interest. Announced in Bowling Green, Kentucky, on November 2, 2026, and set against the lavish backdrop of an upcoming New York City event cohosted by Cosmopolitan, it's less about...

China-CEEC Forum Sparks Robust SME Partnerships

There’s a fresh buzz around Cangzhou's efforts to galvanize business opportunities between China and Central and Eastern Europe. The 7th China-CEEC SME Forum, kicking off in this city of Hebei Province, isn’t just another meeting of the minds. Nope, it’s like a marketplace thrown into overdrive—where AI strategies and logistics are shaping up to be the star...

Wincomm & Portwell Unveil Medical AI Tech at MEDICA 2026

MEDICA 2026: Wincomm and Portwell Join Forces November's got one heck of an event lined up with MEDICA 2026, where Wincomm and Portwell are teaming up to showcase what they've got up their sleeves in medical AI computing. This whole shebang runs from November 16 to 19, with their setup in Hall 12, Stand C76, Düsseldorf, Germany. But why should investors care? Because...

Dun & Bradstreet's Merger Sparks Legal Showdown

Shake-Up in Investor Circles Over D&B Class Action Lemme tell ya, Dun & Bradstreet Holdings (NYSE:DNB)—that name is echoing through courtrooms these days. It's like watching an old time Wall Street brawler go a few rounds with a heavyweight. Investors better sit tight because we've got a class action cooked up, and the lead plaintiff deadline smacks us in the face on...

Mind Meets Soul: Neuroscience and Spiritual Pathways

The Brain, Stress, and Spiritual Practices Ever tried to meditate and wondered if it actually does a number on your mind? Well, here comes Dr. Helen Lavretsky, who’s delving into the nitty-gritty of what happens up there when stress hits and spirituality steps in. This session on November 10 is bound to be a humdinger in the realm of science-meets-spirit. If you've ever...